Neonatal candidiasis: clinical spectrum and epidemiology in a tertiary care centre

Authors

  • Bhavana Koppad Department of Pediatrics, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, India
  • Kulkarni Poornima Prakash Department of Pediatrics, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20170684

Keywords:

Candida albicans, Neonatal candidiasis, NICU

Abstract

Background: Candidial infections are a serious problem in neonatal intensive care units (NICU) which increases the mortality and morbidity in addition to increasing health care costs. Confirming the diagnosis by laboratory tests is difficult and a high index of suspicion is required. The objective of this study was to identify the clinical spectrum and epidemiology of neonatal candidiasis in a tertiary care NICU.

Methods: The present study was carried out in the NICU of SDM medical college and hospital, Dharwad. All babies who were admitted to NICU and who had positive blood culture for Candida were included in the study. One year Data (1st December 2015 to 31st November 2016) was collected retrospectively from NICU case records. Statistical test used was chi square test.

Results: Total admissions to the NICU during the study period were 2591. Blood cultures were positive in 132 babies. Among these, Candidial sepsis was noted in 39.39% (52) babies. Out of the 52 positive fungal cultures, 15 were Candida albicans, 35 were Candida non albicans and 2 were mixed cultures (Candida albicans and non albicans) showing an increasing incidence of non-albicans Candida infections. Among the non albicans Candida, Candida tropicalis and Candida guilliermondii were the predominant species (11 each) followed by Candida famata (6), Candida krusei (6) and Candida parapsilosis (3). Candidial sepsis was seen to be more common among preterm and low birth weight babies. Usage of antibiotics, Total parenteral nutrition (TPN) and mechanical ventilation were common risk factors noted in our study.

Conclusions: Systemic Candidiasis is a disease of modern neonatal intensive care. It deserves urgent attention for its prevention as well as effective treatment in order to minimize neonatal morbidity and mortality.

References

Mokhtar E, El-Shereef A, Abdel Kader A, Al-Tounisy A, Karam El-Din A. Early Diagnosis of Neonatal Sepsis caused by Yeast Infection. Austin J Public Health Epidemiol. 2014;1(2):1006.

Kumar A, Yadav A. Study of risk factors for Candida species colonization of neonatal intensive care unit patient. Int J Pharma Bio Sci. 2012;3(2):B193-199.

Niranjan HS. An emerging threat of Non-Albicans Candida Infection in Tertiary care neonatal intensive care units. Sch J App Med Sci. 2015;3(7B):2583-5.

Montagna MT. Invasive fungal infections in neonatal intensive care units of Southern Italy: a multicentric regional active surveillance. J Prev Med Hyg. 2010;51:125-30.

Schellack N, Gous AGS. Amphotericin B in the management of fungal infections in a neonatal intensive care unit: experiences in a teaching hospital. South Afr J Epidemiol Infect. 2012;27(1):24-9.

Rao S, Ali U. Systemic fungal infections. J Postgrad Med. 2005;51(1):27-8.

Ariff S. Clinical spectrum and outcome of neonatal Candidiasis in a tertiary care hospital in Karachi, Pakistan. J Infect Dev Ctries. 2011;5(3):216-23.

Kapila S. Indentification of Candida species in neonatal septicemia. Int J Contemp Pediatr. 2016;3(2):601-5.

Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. 2000;19:319-24.

Howell A, Isaacs D, Halliday R, Australasian study group for neonatal infections. Oral nystatin prophylaxis and neonatal fungal infections. Arch Dis Child Fetal Neonatal Ed. 2009;94:429-33.

Segal E. Candida still number one- what do we know and where are we going from here? Mycoses. 2005;48:3-11.

Benjamin DK, Stoll BJ. Neonatal Candidiasis: epidemiology, risk factors, and clinical judgement. Pediatr. 2010;126(4):e865-873.

Femitha P, Joy R. Candidaemia in neonatal ICU- experience from a tertiary care hospital. Curr Pediatr Res. 2013;17(1):44-8.

Benjamin DK, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. National institute of child health and human development neonatal research network. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to22 months. Pediatrics. 2006;117(1):84-92.

Borderon JC, Ferly MT, Selika E, Langier J, Quentin R. Prevention of Candida colonisation prevents infection in a neonatal unit. Biol Neonate. 2003;84:37-40.

Mendritta DK, Rawat V, Thamke D, Chaturvedi P, Chabra S, Narang P, et al. Candida colonisation in preterm babies admitted to neonatal intensive care unit in the rural setting. Ind J Med Microbiol. 2006;24:263-7.

Heljic S, Hukic M, Dzinovic A, Dozic M, Basu M. Fungal colonisation of newborn in neonatal intensive care unit. Med Arh. 2005;59:211-3.

Downloads

Published

2017-02-22

Issue

Section

Original Research Articles